MD Pharma Consulting Group
Devoted to drug development
Research and Development
1- Pharmacokinetics (PK), Pharmacodynamics (PD), and PK/PD Modelling
MD Pharma Consulting Group provides Pharmacokinetic and Pharmacodynamic services that include:
Pharmacokinetic/Pharmacodynamic (PK/PD) Analysis.
Pharmacokinetic/Pharmacodynamic (PK/PD) Modelling.
Non-Clinical Absorption, Distribution, Metabolism, and Excretion (ADME) Studies.
MD Pharma Consulting Group Bioinformatics experts support sponsors and industry partners on various Bioinformatics applications that include:
Gene Prediction and Genome Annotation.
Computer-Aided Drug Design.
MD Pharma Consulting Group evaluates Toxicology studies as the Single Dose Acute Toxicity studies, Repeated Dose Chronic Toxicity studies, and the Developmental and Reproductive Toxicology (DART) Studies and determines the Maximum Tolerated Dose (MTD) in accordance with ICH M3(R2), Guidance on Nonclinical Safety Studies for the Conduct of Human Clinical Trials and Marketing Authorization for Pharmaceuticals.